Drugs / Cell therapy with bispecific antibodies
Cell therapy with bispecific antibodies
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00149019 | May 2002 → Sep 2005 | metastatic neoplasm | Hadassah Medical Organization | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cell therapy with bispecific antibodies | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00149019 ↗ |
| Modality | Cell therapy | “Cell therapy with bispecific antibodies” NCT00149019 ↗ |